223 related articles for article (PubMed ID: 19578752)
1. Small interference RNA-mediated suppression of overexpressed cyclin E protein restores G1/S regulation in NIH-OVCAR-3 ovarian cancer cells.
Todd MC; Spruill SC; Meerbrey KL
Int J Oncol; 2009 Aug; 35(2):375-80. PubMed ID: 19578752
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer cells that coexpress endogenous Rb and p16 are insensitive to overexpression of functional p16 protein.
Todd MC; Sclafani RA; Langan TA
Oncogene; 2000 Jan; 19(2):258-64. PubMed ID: 10645004
[TBL] [Abstract][Full Text] [Related]
3. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
5. Processing of cyclin E differs between normal and tumor breast cells.
Harwell RM; Porter DC; Danes C; Keyomarsi K
Cancer Res; 2000 Jan; 60(2):481-9. PubMed ID: 10667604
[TBL] [Abstract][Full Text] [Related]
6. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
Yu X; Liu L; Cai B; He Y; Wan X
Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.
Kaproth-Joslin KA; Li X; Reks SE; Kelley GG
Biochem J; 2008 Nov; 415(3):439-48. PubMed ID: 18588506
[TBL] [Abstract][Full Text] [Related]
8. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E
Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression.
Zhang D; Vuocolo S; Masciullo V; Sava T; Giordano A; Soprano DR; Soprano KJ
Oncogene; 2001 Nov; 20(55):7935-44. PubMed ID: 11753676
[TBL] [Abstract][Full Text] [Related]
10. TSG101 expression in gynecological tumors: relationship to cyclin D1, cyclin E, p53 and p16 proteins.
Bennett NA; Pattillo RA; Lin RS; Hsieh CY; Murphy T; Lyn D
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1187-93. PubMed ID: 11838966
[TBL] [Abstract][Full Text] [Related]
11. Induction of senescence by progesterone receptor-B activation in response to cAMP in ovarian cancer cells.
Takahashi A; Kato K; Kuboyama A; Inoue T; Tanaka Y; Kuhara A; Kinoshita K; Takeda S; Wake N
Gynecol Oncol; 2009 May; 113(2):270-6. PubMed ID: 19211137
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
[TBL] [Abstract][Full Text] [Related]
13. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
[TBL] [Abstract][Full Text] [Related]
14. Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus.
Wolf JK; Kim TE; Fightmaster D; Bodurka D; Gershenson DM; Mills G; Wharton JT
Gynecol Oncol; 1999 Apr; 73(1):27-34. PubMed ID: 10094876
[TBL] [Abstract][Full Text] [Related]
15. Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.
Leong CT; Ong CK; Tay SK; Huynh H
Oncogene; 2007 Feb; 26(6):870-80. PubMed ID: 16862170
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle dysregulation influences survival in high risk breast cancer patients.
Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclins A, E and topoisomerase II alpha correlates with centrosome amplification and genomic instability and influences the reliability of cytometric S-phase determination.
Kronenwett U; Castro J; Roblick UJ; Fujioka K; Ostring C; Faridmoghaddam F; Laytragoon-Lewin N; Tribukait B; Auer G
BMC Cell Biol; 2003 Jul; 4():8. PubMed ID: 12875657
[TBL] [Abstract][Full Text] [Related]
18. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
19. Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.
Spruck C; Sun D; Fiegl H; Marth C; Mueller-Holzner E; Goebel G; Widschwendter M; Reed SI
Cancer Res; 2006 Jul; 66(14):7355-60. PubMed ID: 16849587
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer.
Wikman H; Kettunen E
Expert Rev Anticancer Ther; 2006 Apr; 6(4):515-30. PubMed ID: 16613540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]